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Aim: To evaluate factors related to the occurrence of Sheehan syndrome. 
Materials and Methods: The obstetrical DIC score, total volume of hemorrhage, shock 
index, level of consciousness at the time of shock occurrence, and pituitary MRI findings 
were evaluated in nine women who showed massive hemorrhage during delivery. These 
clinical outcomes were analyzed in all these patients who were prospectively followed-up 
to identify any possible occurrence of Sheehan syndrome.   
Results: Comparing to six women with non-Sheehan syndrome, three women who were 
diagnosed with Sheehan syndrome showed significant elevation of the obstetrical DIC 
score, decrease in the level of consciousness during shock, and remarkable pituitary gland 
atrophic change with an empty sella turcica detected by pituitary MRI. The volume of 
hemorrhage during delivery and shock index were not significantly different between 
these two groups of women.  
Conclusions: Careful attention and follow-up should be paid to women with postpartum 
massive hemorrhage in order to early detection and management of women with Sheehan 
syndrome.  
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Introduction 
 Sheehan syndrome is the name given to postpartum hypopituitarism and is 
caused by an infarction in the adenohypophysis, usually precipitated by massive uterine 
hemorrhage. Sheehan syndrome, an endocrine disease, was first reported in 1937 by the 
English pathologist Harold Leeming Sheehan on the basis of autopsy findings in patients 
with postpartum pituitary necrosis 1-3. Postpartum massive hemorrhage is one of the 
causes of ischemia-induced pituitary dysfunction secondary to the arrest of blood flow to 
the adenohypophysis. Necrotized areas of the adenohypophysis undergo organization, 
form a fibrous scar leading to time-dependent atrophic change of pituitary gland resulting 
in empty sella turcica, the lodging bed of pituitary gland, which can be clinically detected 
by magnetic resonance imaging (MRI).  
Clinically, women with Sheehan syndrome exhibited dysfunction of the 
anterior lobe of the pituitary gland with the manifestation of obstetrical shock 
accompanied by DIC during delivery. Decreased endocrine function can be restricted to 
one hormone or can affect all hormones secreted by adenohypophysis cells. Clinical 
 
presentation varies and is dependent on the age of the patient, rapidity of onset, 
nature/causes of the pathological process, and the proportion of the affected 
adenohypophysis cells. Functional impairment occasionally extended to the posterior 
lobe of the pituitary.  
While the incidence is low, being 1 out of 10,000 cases of delivery 2, it is a 
serious disease, and its pathological factors largely remain unclear. It is a hazardous 
disease that may not only impair the quality of life of women but also may threaten life if 
left untreated. Mild hypopituitarism can remain undetected for years but complete loss of 
adenohypophysis function requires immediate treatment. Therefore, careful follow-up 
intervention for early diagnosis and proper management of patients with Sheehan 
syndrome is mandatory. However, information on the suitable clinical factors related to 
the occurrence of Sheehan syndrome is scanty.  
In our current study, we followed-up a group of women had suffered from 
massive hemorrhage during delivery to identify the possible occurrence of Sheehan 
syndrome. Secondly, we plan to analyze a number of obstetrical factors and hormonal 
parameters in these women during the course of follow-up. 
 
Subjects and Methods 
 All subjects in this study were women of reproductive age who attended our 
University hospital for screening and follow-up after achieving pregnancy. A total of nine 
women who suffered from massive hemorrhage during delivery was followed-up for a 
period of 13-80 months to identify any subsequent occurrence of Sheehan syndrome. 
Massive hemorrhage was defined as a loss of ≥3,000g of blood including amniotic fluid. 
Mean age ranges from 29-41years and gestational week at delivery ranges from 
31wks-41wks in these women. All women had at least one or more than one children. 
During this follow-up period, any woman suspected to have Sheehan syndrome on the 
basis of clinical findings and hormonal profiles were referred to the Department of 
Internal Medicine of our University for final diagnosis by MRI.  
 Our current study is in accordance with the guidelines of the Declaration of 
Helsinki and was performed with the approval by the Institutional Review Board of 
Nagasaki University. An informed consent was obtained from all participated women.  
  The obstetrical DIC score, total volume of hemorrhage, shock index (S.I.), 
level of consciousness, electrolyte levels, and pituitary MRI findings were evaluated in 
 
these women. The S.I. was shown as the maximum value during shock, and the level of 
consciousness was graded according to the criteria of Glasgow Coma Scale (GCS).4 The 
GCS criteria is based on a scoring system depending on eye response (score 1-4), verbal 
response (score 1-5) and motor response (score 1-6). A tendency towards higher GCS 
score indicates good consciousness level and a tendency towards decreased GCS score 
denotes bad consciousness level. The scoring system of consciousness level as measured 
by Japan Coma Scale (JCS) is somehow similar to that of GCS score.  
Serum levels of hormones being secreted by the anterior lobe of the pituitary 
gland such as growth hormone (GH), luteinizing hormone (LH), follicle stimulating 
hormone (FSH), prolactin (PRL), thyroid stimulating hormone (TSH), and 
adrenocorticotropic hormone (ATCH) as well as estradiol (E2), insulin-like growth factor 
1 (IGF-1), free thyroxine (FT4), and cortisol were measured by commercial based 
Immulyze assay.  
All results are expressed as mean ± SD. The clinical characteristics of the 
subjects were compared with one-way analysis of variance. Any difference of clinical 
factor or hormonal profile between two groups was analyzed by the non-parametric 
 
Mann-Whitney U-test or Student’s t-test. Due to small number of cases in each group, we 
confirmed the validity of our results by Fisher’s exact test. A value of p<0.05 was 
considered statistically significant.  
Results 
 During the follow-up period after postpartum massive hemorrhage, three cases 
were diagnosed as Sheehan syndrome (Sheehan group) and the remaining six cases did 
not develop Sheehan syndrome despite massive hemorrhage during delivery 
(non-Sheehan group). Obstetrical backgrounds of these two groups of cases are shown in 
Table 1. Symptoms suggestive of deficiency of pituitary anterior lobe hormones such as 
breast atrophy, poor milk secretion, hair loss, and malaise were observed from early in the 
puerperal period in the Sheehan group but not in the non-Sheehan group. The clinical 
backgrounds of three cases in the Sheehan group are described here briefly. 
CASE 1 
 This patient (34 yrs old) was admitted to our department in January 2006 at 33 
weeks of gestation due to pregnancy complicated by uterine myoma and threatened 
premature labor and underwent emergency Caesarean section due to placental abruption 
 
on the 5th hospital day. Uterine bleeding did not stop even after Caesarean section, and 
emergency supra-vaginal amputation of the uterus was carried out. Breast atrophy and 
hair loss of the head and pubic region were noted immediately after surgery. Estrogen 
replacement therapy was introduced 3 months after surgery due to decreased serum 
estradiol level. A diagnosis of Sheehan syndrome was made (LH and FSH: low response, 
PRL: low response, ACTH and cortisol: low response, TSH: normal response) based on 
the pituitary anterior lobe hormone stimulation tests [LH-RH test (LH, FSH), TRH test 
(TSH, PRL), CRH test (ACTH, cortisol), and GHRP-2 test (GH)] 4 years after surgery.  
CASE 2 
 The patient (39 yrs old) with a history of previous Caesarean section underwent 
repeated Caesarean section again in November 2009 at 39 weeks of gestation and was 
referred to our department for emergency treatment due to marked adhesion in the 
abdominal cavity and failure to achieve complete hemostasis by suturing. After her 
arrival, emergency supra-vaginal amputation of the uterus was carried out, but arterial 
hemorrhage from the vaginal wall persisted, and hemostasis was eventually achieved by 
trans-catheter arterial embolization. After surgery, no milk secretion was noted, but hot 
 
flushes and mild hair loss were observed. She also became languid, showed little change 
in emotion, and gave the impression that her personality had changed. Six months after 
surgery, pituitary anterior lobe hormone stimulation tests were performed, and a 
diagnosis of Sheehan syndrome was made based on abnormal hormonal profiles (LH and 
FSH: low response, PRL: low response, ACTH, cortisol: low response, TSH: normal 
response, and marked growth hormone deficiency). 
CASE 3 
 In June 2008, this patient (38 yrs old) underwent induction of labor using 
oxytocin for weak pain and subsequently an emergency Caesarean section was performed 
due to placental abruption. Uterine bleeding did not stop due to atonic bleeding even after 
abdominal closure, and the patient was transferred to our department for emergency 
treatment. After arrival, bleeding was stopped using a uterine contractor. No milk 
secretion was observed after surgery, amenorrhea persisted even 8 months after surgery, 
and the blood estradiol level was low. Therefore, HRT was initiated one year and five 
months after surgery. Easy fatigability, headache, dizziness, and loss of libido were also 
noted after surgery. Two years after surgery, pituitary anterior lobe hormone stimulation 
 
tests were performed, and a diagnosis of Sheehan syndrome was made by abnormal 
hormonal profiles (LH and FSH: low response, PRL: low response, TSH, ACTH, 
cortisol: normal response, and growth hormone deficiency). 
 Table 2 shows the obstetrical DIC score, total volume of hemorrhage, shock 
index (S.I.), status of consciousness level, and findings on pituitary MRI in 9 cases. 
Between Sheehan and non-Sheehan groups, the total volume of hemorrhage was 9143.3g 
(4,500-11,500) vs. 6695g (3,260-10,900) (p=0.365), and S.I. was 3.03 (2.8-3.3) vs. 2.55 
(1.6-3.5) (p=0.311), respectively, showing no significant difference, but the mean 
obstetrical DIC score was 16.3 (15-18) vs. 9.5 (7-13) (p=0.004), respectively, being 
significantly higher in the Sheehan group than in the non-Sheehan group. On pituitary 
MRI, also, an empty sella was noted in one case and pituitary atrophy in two cases in the 
Sheehan group, but no pituitary abnormality was observed in the non-Sheehan group (Fig. 
1). The mean GCS score was 5.3 in the Sheehan group and 14.8 in the non-Sheehan group. 
GCS score was significantly low in cases with Sheehan syndrome (p=0.0009) than in 
non-Sheehan syndrome. The level of consciousness based on Japan Coma Scale was JCS 
0 or I (being conscious) in all cases in the non-Sheehan group but JCS II-30 and/or JCS 
 
III-300 (arose with stimuli or on command) in all patients in the Sheehan group, showing 
a significant decrease in the level of consciousness in the later group (Fisher’s exact test, 
p=0.01). 
 Table 3 shows hormonal profiles in the sera of patients in the Sheehan group 
and non-Sheehan group. A decreased level of all measured hormones (except ACTH) was 
observed in patients in the Sheehan group when compared with cases in the non-Sheehan 
group. Although not statistically significant, serum GH/FSH levels were decreased to 
almost half and LH level was decreased to one third in cases of Sheehan group comparing 
to similar hormones levels in cases of non-Sheehan group (Table 3). Serum E2 level was 
undetectable (below cut off value, <10pg/ml) in all cases with Sheehan syndrome in 
contrast to cases in the non-Sheehan group, Therefore, we could not analyze statistical 
difference of E2 levels between these two groups (Table 3). A statistically significant 
increase in basal hormone levels of ACTH (p=0.011) and decrease in levels of IGF-1 
(p=0.048) was observed in the Sheehan group than in non-Sheehan group. Two cases of 
Sheehan syndrome with low cortisol level are now under treatment with cortical by 
doctor of Internal medicine in order to optimize the level of ACTH to the level of 
 
non-Sheehan group. Another case with Sheehan syndrome was not indicated for cortisol 
treatment because basal cortisol level in this case was similar to that in non-Sheehan 
group. We also observed an increased tendency in TSH levels in sera (p=0.061) of 
patients in the Sheehan group.  
Although data not shown, we also measured a number of electrolyte levels in 
the sera of patients in the Sheehan and Sheehan group. Serum levels of sodium were 
markedly reduced to 124 mEq/L in two cases in the Sheehan group and levels of sodium 
were within normal range in all cases in the non-Sheehan group (data not shown). After 
correction for albumin, serum calcium level was still low in both groups without showing 
any difference between these two groups (data not shown).  
Discussion 
 Sheehan syndrome is a permanent secretion disorder of all pituitary anterior 
lobe hormones caused by extensive pituitary necrosis secondary to obstetrical shock 
accompanied by DIC following massive hemorrhage during delivery. No pituitary 
dysfunction develops if about 50% of the normal pituitary gland remains intact,3 but 
partial or panhypopituitarism is reported to occur if 70-90% of the pituitary gland is 
 
necrosed.5 Depending on the site and size of the necrosed area of the pituitary gland, the 
disease varies from panhypopituitarism (Sheehan syndrome), in which the secretion of all 
gonadal, thyroid, and adrenocortical hormones is reduced, to partial hypopituitarism, in 
which the secretion of 2 or more hormones is reduced, and to single-hormone 
hypopituitarism, in which the secretion of only one hormone is reduced.  
In our current study of nine cases with massive post-partum hemorrhage, we 
could detect three cases with Sheehan syndrome after combined and careful follow-up of 
these patients by Obstetrics doctors and doctors from Internal Medicine. All these three 
cases showed necrotic pituitary gland on MRI image and significant decrease in serum 
levels of at least two hormones (estradiol/IGF-1) when compared with cases in the 
non-Sheehan group. In fact, we found a decreased tendency of all pituitary anterior lobe, 
gonadal and thyroid hormones (except ACTH) in cases with Sheehan syndrome.   
Among all measured hormone levels in sera, we found significantly increase/decrease in 
the basal levels of ACTH/IGF-1, respectively and an increased tendency in the levels of 
TSH in cases in the Sheehan group than in non-Sheehan group. All other decreased or 
undetectable hormone levels in Sheehan group failed to achieve a significant difference 
 
comparing to non-Sheehan group. This could be due to small number of cases in each 
group.  
There is a mutual feed-back loop between ACTH and cortisol. The minimal 
decrease of cortisol level in Sheehan group (Table 3) stimulates the secretion of ACTH in 
a positive feed-back mechanism in an attempt to compensate the damage of anterior 
pituitary lobe. This may explain the significantly increased basal ACTH levels in three 
cases with Sheehan syndrome comparing to cases in the non-Sheehan group. Two cases 
of Sheehan syndrome with low cortisol level are now under cortisol treatment by doctor 
of Internal medicine in order to normalize the level of ACTH to the level of non-Sheehan 
group. According to the comment of doctor of Internal medicine, basal cortisol level is 
important in the decision of cortisol treatment. Another case with Sheehan syndrome was 
not indicated for cortisol treatment, because basal cortisol level was similar to that of 
cases in the non-Sheehan group.  
Besides reduction in hormone levels, we also found a significant increase in 
DIC score and significantly decreased levels of consciousness in patients with Sheehan 
syndrome. We could not find any significant difference in the total volume of hemorrhage 
 
or shock index between these two groups. This might be due to less number of cases in 
our current study.      
It has been reported that deficiency of milk secretion is a frequent initial 
symptom of Sheehan syndrome, that symptoms such as breast atrophy, sense of fatigue, 
loss of pubic and axillary hair, and continuation of amenorrhea, and that hypothyroidism 
and hypoadrenalism are observed for several months to a few years. Sert et al. reported 
insufficiency of milk secretion in 26 of 28 patients diagnosed with Sheehan syndrome,6 
and Kelestimur mentioned insufficiency of milk secretion as one of the diagnostic criteria 
for Sheehan syndrome.7 Of the 3 patients with Sheehan syndrome encountered at our 
department, insufficiency of milk secretion was observed in 2, and it is considered to be 
an important early puerperal symptom that may suggest Sheehan syndrome. Together 
with insufficient gonadotropin secretion, subsequent onset of breast atrophy and loss of 
pubic and axillary hair may be considered as an early indication of Sheehan syndrome as 
we experienced in our three cases.  
Although GCS scoring system is internationally recognized to measure levels 
of consciousness, as an additional marker, we found in our current study that JCS was 
 
also equally useful for the evaluation of consciousness level.7 In fact, similar to decreased 
GCS scores, we also found a score of JCS II-30 and/or JCS III-300 in all cases with 
Sheehan syndrome. The decreased levels of consciousness in cases with Sheehan 
syndrome can be explained by hyponatremia as we observed in two of our three cases. 
Hyponatremia in patients with Sheehan syndrome may be secondary to suppression of 
ADH secretion which could be a result of declining cortisol secretion.9,10 Sert et al. 
measured serum sodium level, evaluated level of consciousness, and performed pituitary 
MRI or CT in patients with Sheehan syndrome. They found a link between hyponatremia 
and an empty sella in many patients exhibiting a reduced level of consciousness such as 
coma and confusion.7 In our cases, abnormalities such as an empty sella were noted in all 
patients in the Sheehan group by pituitary MRI, but no atrophic abnormality was 
observed in the non-Sheehan group. Kaplun et al. reported a patient who showed massive 
hemorrhage during delivery, a low-signal area on pituitary MRI on Day 26 after delivery, 
and exhibited an empty sella 6 months after delivery.11 Therefore, serial pituitary MRI 
from the early puerperal period may be considered necessary and recommended in 
patients with massive hemorrhage during delivery in order to early identify and detect 
 
cases with Sheehan syndrome. 
 Sheehan syndrome is a rare but irreversible and serious disorder. When most 
pregnant women, who suffer massive hemorrhage or shock during delivery, survive and 
are rehabilitated, some patients are considered to have one-hormone hypopituitarism 
rather than panhypopituitarism such as typical Sheehan syndrome. However, publications 
on obstetrical predictive factors targeting to early identify or diagnose this debilitating 
disease are still inadequate. With strict prospective follow-up, here we demonstrated for 
the first time some subjective, hematological, hormonal and MRI imaging parameters 
which might be suitable in clinical practice to isolate and early diagnosis of Sheehan 
syndrome in groups of women had massive post-partum hemorrhage. In addition to 
subjective findings of insufficient or no milk secretion and breast atrophy, our current 
findings of decreased consciousness level and elevated obstetrical DIC score in women 
with massive post-partum hemorrhage may give us some additional clue in the isolation 
and early diagnosis of cases with Sheehan syndrome. Further study on this issue is 
necessary to strengthen our current findings.   
Considering future QOL, early diagnosis of Sheehan syndrome based on our 
 
clinical findings is important for proper management of these patients by mutual 
collaboration and discussion between Obstetrical doctors and doctors from Internal 
Medicine. Basal cortisol and ACTH level may be an important parameter in decision 
making for cortisol treatment in order to normalize ACTH level in cases with Sheehan 
syndrome. Furthermore, careful attention and strict follow-up are mandatory for any 
women with massive past-partum hemorrhage in order to search cases with Sheehan 
syndrome. 
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Figure 1. Shows normal (left side) and abnormal (right side) pituitary gland by   
T2 weighted image of magnetic resonance image (MRI). The red arrow and circle on the 
left side shows iso-intensity to hyper-intensity area filling the sella turcica indicating 
normal pituitary gland. The red arrow and circle on the right side shows hypo-intensity 






Table 1.Clinical profiles and obstetrical background of cases with and without Sheehan syndrome 
 Sheehan group (n=3) non-Sheehan group (n=6) 
mean age in yrs. (range) 41.7±0.6 (41-42) 32.2±1.9 (29-34) 
gravida 2.0±1.0 2.17±1.6 
para 2.0±1.0 2.17±1.6 
weeks of gestation         at 
delivery (range) 
37.7±3.2 (34-40) 37.7±3.9 (31-41) 
mode of delivery Caesarian section (n=3) Caesarian section (n=3) 
vaginal (n=3) 
cause of hemorrhage placental abruption (n=2) 
insufficient suturing of uterine wall (n=1) 
uterine rupture (n=1) 
atonic bleeding (n=2) 
retroperitoneal hematoma (n=2) 
placenta previa (n=1) 
hysterectomy 2 cases (66.7%) 3 cases (50%) 
symptom/sign breast atrophy 
lack of breast milk 




follow-up months after 
delivery (range) 
51.3±28.5 (23-80) 19.5±5.9 (13-27) 
The results are expressed as mean±SD.  
 
Table 2. Obstetrical outcome and image findings of cases with and without Sheehan syndrome 
 Sheehan group (n=3) non-Sheehan group (n=6) P value 
DIC score 16.3±1.5 9.5±2.6 0.004 
Total bleeding (g) 9143.3±4021.4 6695.0±3376.0 0.365 
Shock Index 3.03±0.25 2.55±0.72 0.311 
GCS score 5.3±4.5 14.8±0.4 0.0009 
Level of consciousness 
based on JCS criteria 
drowsy but can be aroused 
with stimuli (n=3 ) 
can be aroused without 
stimuli (n=6 ) 
0.01 
MRI of pituitary gland empty sella (n=1) 
atrophy (n=2) 
normal (n=6) — 
The results are expressed as mean±SD. Statistics were analyzed by Student’s t-test or Fisher’s  





Table 3. Hormonal profiles in sera of patients with and without Sheehan syndrome 
 normal value (range) Sheehan group (n=3) non-Sheehan group (n=6) p value 
GH 0.28~1.64ng/ml 0.93±0.46 1.69±2.06 0.235 
LH 1.4~15mIU/ml(follicular phase) 
0.5~15mIU/ml(luteal phase) 
4.42±4.50 13.31±16.30 0.398 
FSH 3~10mIU/ml(follicular phase) 
1.3~6.2mIU/ml(luteal phase) 
7.39±3.39 15.62±25.46 0.607 
PRL 5~30ng/ml 13.81±4.55 15.13±10.25 0.842 
TSH 0.45~5.08μIU/ml 2.98±1.63 1.50±0.41 0.061 
ACTH 7~56pg/ml 25.8±10.7 10.9±2.8 0.011 
Estradiol 20~350pg/ml(follicular phase) 
45~300pg/ml(luteal phase) 






8.42±2.90 9.04±3.56 0.804 
IGF-1 73~311ng/ml 66.3±43.7 149±50.8 0.048 
Free T4 0.95~1.57ng/dl 1.06±0.18 1.19±0.17 0.334 
The results are expressed as mean±SD. GH, growth hormone; LH, luteunizing hormone; 
FSH, follicle-stimulating hormone; PRL, prolactin; TSH, thyroid stimulating hormone;  
ACTH, adrenocorticotropin hormone; IGF-1, insulin growth factor-1; free T4, free thyroxine 
 
 
 
